Closed System Drug Transfer Device Market Player and Forecast to 2027

The global closed system drug-transfer device market is driven by an increased risk of chromosomal abnormalities associated with hazardous drug exposure in all healthcare workers, rising cancer cases, a growing number of oncology drug approvals, and restricting regulatory guidelines regarding the safe handling and use of hazardous drugs. Many hazardous cancer drugs used to treat cancer may have toxic properties such as alkylating antineoplastic agents that may bind to and cause irreversible DNA damage in humans. Rising awareness about CSTD products among end-users, especially in developing countries, will be expanding the growth at a significant pace during the forecast period. Meanwhile, limited technological progress and underdeveloped healthcare industry in some regions are projected to hamper the closed system transfer device (CSTD) market.

The entire closed system drug transfer device market has been sub-categorized into type, delivery and end-user. current and future demand for closed system drug transfer device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

The major players in the closed system drug transfer device market include BD Medical, Equashield, ICU Medical, Teva Medical Ltd., CorvidaMedical, B. Braun.

By Type

  • Barrier-Type
  • Filtration-Type

By Delivery

  • Closed Vial Access Devices
  • Closed Bag/Line Access Devices
  • Closed Syringe Safety Devices

By End-User

  • Specialty Centers
  • Hospitals & Clinics
  • Others

Source: https://www.valuemarketresearch.com/report/closed-system-drug-transfer-device-market

Leave a Reply

Your email address will not be published. Required fields are marked *

Social Media Auto Publish Powered By : XYZScripts.com